Collegium Pharmaceutical Correlations

COLL Stock  USD 47.91  0.48  1.01%   
The current 90-days correlation between Collegium Pharmaceutical and Methode Electronics is 0.13 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Collegium Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Collegium Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Collegium Pharmaceutical Correlation With Market

Modest diversification

The correlation between Collegium Pharmaceutical and DJI is 0.24 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Collegium Pharmaceutical and DJI in the same portfolio, assuming nothing else is changed.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collegium Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.

Moving together with Collegium Stock

  0.89600080 Ginwa EnterprisePairCorr
  0.73300110 Huaren PharmaceuticalPairCorr
  0.75VTRS Viatris Aggressive PushPairCorr
  0.75VTYX Ventyx Biosciences Buyout TrendPairCorr
  0.85300086 Hainan Honz PharmacePairCorr
  0.82AUROPHARMA Aurobindo PharmaPairCorr
  0.66300255 Hebei Changshan BiochemPairCorr
  0.89TORNTPHARM Torrent PharmaceuticalsPairCorr

Moving against Collegium Stock

  0.91KG Kestrel Group, Symbol ChangePairCorr
  0.82WINDLAS Windlas BiotechPairCorr
  0.82600129 Chongqing Taiji IndustryPairCorr
  0.75WEED Canopy Growth CorpPairCorr
  0.69ELTX Elicio TherapeuticsPairCorr
  0.63BIOFILCHEM Biofil Chemicals PhaPairCorr
  0.62002262 Jiangsu Nhwa PharmacPairCorr
  0.61CRDL Cardiol TherapeuticsPairCorr
  0.61300181 Zhejiang Jolly PharmPairCorr
  0.6002287 Tibet Cheezheng TibetanPairCorr
  0.59NXS Next SciencePairCorr
  0.57HIKAL Hikal LimitedPairCorr
  0.56300725 PharmaBlock SciencesPairCorr
  0.52600381 Qinghai Spring MedicinalPairCorr
  0.52CAPLIPOINT Caplin Point LaboratoriesPairCorr
  0.47688321 Shenzhen ChipscreenPairCorr
  0.46600521 Zhejiang Huahai PharPairCorr
  0.46603676 Tibet Weixinkang MedicinePairCorr
  0.42HCM HUTCHMED ChinaPairCorr
  0.32002332 Zhejiang Xianju PharPairCorr
  0.81TSND TerrAscend CorpPairCorr
  0.78301015 Qingdao Baheal MedicalPairCorr
  0.77ETON Eton PharmaceuticalsPairCorr
  0.77CGC Canopy Growth CorpPairCorr
  0.76ACB Aurora CannabisPairCorr
  0.76HIK Hikma Pharmaceuticals PLCPairCorr
  0.71XERS Xeris PharmaceuticalsPairCorr
  0.7600422 KPC PharmaceuticalsPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

KLGGPPBV
SAMSTMEF
UMCCAOEF
UMCBHE
SAMMEI
STMEFMEI
  

High negative correlations

SAMBHE
STMEFBHE
CAOEFMEI
BHEMEI
SAMUMC
UMCMEI

Risk-Adjusted Indicators

There is a big difference between Collegium Stock performing well and Collegium Pharmaceutical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Collegium Pharmaceutical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Collegium Pharmaceutical Corporate Management

Shirley JDGeneral VPProfile
Bart DunnExecutive DevelopmentProfile
Scott SudduthHead OperationsProfile
Christopher MDVice RelationsProfile
Ian MBAHead RelationsProfile